InvestorsHub Logo
Followers 454
Posts 21811
Boards Moderated 7
Alias Born 01/20/2005

Re: None

Wednesday, 10/19/2011 1:03:42 PM

Wednesday, October 19, 2011 1:03:42 PM

Post# of 1166
CEMI $0.445,,,, ChemBio Diagnostics DPP international patent protection expanding

Chembio Diagnostics reported that its Dual Path Platform, DPP, technology has been or will soon be granted patent protection in a number of major markets including Japan, with the Company recently being notified that the DPP? patent has been allowed in Japan and will therefore be issued there shortly. The anticipated issuance in Japan, combined with previous DPP? patent issuances in the United States in 2007, and in the United Kingdom, China, Indonesia, Singapore, Malaysia, Australia, Eurasia, and Mexico more recently provides Chembio with an increasingly global patent protection for DPP? products covering many large and emerging markets. Chembio believes this is important in connection with possible collaborations, distribution agreements, and/or other commercial or strategic transactions, as well as to investors. Furthermore, to the extent DPP? patent applications pending in Europe, South America, Korea, and other jurisdictions result in additional patent DPP? issuances to Chembio, the global footprint of this patent protection would be even further extended.